# Vascularization and Bone Regeneration with 3D-Printed Composite Scaffolds in Rodent Critical-Size Calvarial Defects: Systematic Review

**Authors:** Milda Vitosyte, Melanie Tesing, Sarlota Galinauskaite, Vygandas Rutkunas, Ieva Gendviliene

PMC · DOI: 10.3390/jfb17030115 · 2026-02-27

## TL;DR

This review examines how 3D-printed composite scaffolds improve blood vessel growth and bone regeneration in rodent skull defects.

## Contribution

The study systematically evaluates composite scaffolds using specific vascular and bone regeneration metrics in critical-size calvarial defects.

## Key findings

- Composite scaffolds showed higher new bone area compared to controls (p = 0.031).
- Functional modifications increased vascularized area and new bone area (p = 0.025 and p = 0.038).
- Pore sizes ≥ 400 μm were linked to higher bone volume fraction (p = 0.029).

## Abstract

Rapid vascularization is essential for bone regeneration in oral and maxillofacial surgery. This systematic review synthesised in vivo evidence on 3D-printed composite scaffolds in rodent critical-size calvarial defects quantified by Microfil perfusion and micro-CT. “Composite” was defined as an organic–inorganic construct within the printed scaffold (not a single-phase scaffold with a surface coating). PubMed, MEDLINE, and Web of Science Core Collection were searched for studies published from January 2014 to December 2025. Eligible studies compared composite scaffolds with non-composite (single-phase) scaffolds and/or empty controls and reported vascular outcomes (vessel number, vascularized area) together with bone outcomes (new bone area, bone volume fraction [BV/TV], and bone mineral density). Ten studies met the inclusion criteria. In outcome-specific exploratory analyses, composite scaffolds were associated with higher new bone area than comparators (p = 0.031). Functional modifications were associated with higher vascularized area (p = 0.025) and higher new bone area (p = 0.038), while dual-factor modifications showed the largest gain in new bone area (p = 0.002). Pore sizes ≥ 400 μm were associated with higher BV/TV (p = 0.029). Heterogeneity in designs, follow-up, and reporting, together with small sample sizes, precluded meta-analysis. Composite scaffolds appear promising, but standardised methodologies and improved reporting are needed to define optimal design features and support translation.

## Full-text entities

- **Genes:** Il4 (interleukin 4) [NCBI Gene 287287] {aka Il4e12}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 54250] {aka Fgf-2, Fgf2a, bFGF}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Ahr (aryl hydrocarbon receptor) [NCBI Gene 25690], Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 29373], Cd34 (CD34 molecule) [NCBI Gene 305081]
- **Diseases:** BMD (MESH:D001851), craniofacial defects (MESH:D019465), Defects (MESH:D000013), injury to (MESH:D014947), periodontal disease (MESH:D010510), long-bone defects (MESH:D050398), apical periodontitis (MESH:D010485), tooth (MESH:D014076), caries (MESH:D003731), Dental bone defects (MESH:D001847), VA (MESH:D001927), Calvarial defects (MESH:C537963)
- **Chemicals:** MS (MESH:C005013), graphene oxide (MESH:C000628730), chitosan (MESH:D048271), beta-TCP (MESH:C485817), hydroxyapatite (MESH:D017886), silica (MESH:D012822), Microfil (MESH:D012826), MV-122 (-), FTY720 (MESH:D000068876), polylactic acid (MESH:C033616), oxygen (MESH:D010100), tricalcium phosphate (MESH:C018392)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027258/full.md

---
Source: https://tomesphere.com/paper/PMC13027258